Early recognition and management of immune-related adverse events (irAEs) is critical for the quality care of immunotherapy patients, and involving clinicians from other specialties is key to patient care.
Read how one cancer program developed a multi-specialty immunotherapy toxicity team and the team’s role in improving irAE management, and communication and care coordination between oncology and other specialties such as pulmonary medicine, rheumatology, cardiology, and gastroenterology.
Then, discover the 8 steps to building an Immuno-Oncology Toxicity Team. An at-a-glance companion guide shows the path to improvement.
Download
